Disparities & Inequalities in Ending the HIV Epidemic: Pre-exposure Prophylaxis (PrEP)

Editor’s Note: This post by Maeleigh Tidd is the second in our Pharmaceutical Inequalities series. She explores the recent Ending the HIV Epidemic Initiative in the US, with a particular focus on prevention strategies, specifically PrEP, that are being implemented to assist in ending the epidemic.

Read more